Iovance Biotherapeutics, Inc. (IOVA)
7.63
-0.46
(-5.69%)
USD |
NASDAQ |
Nov 12, 16:00
7.63
0.00 (0.00%)
After-Hours: 07:42
Iovance Biotherapeutics Debt to Equity Ratio : 0.0556 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0556 |
| June 30, 2026 | 0.0625 |
| March 31, 2026 | 0.0662 |
| December 31, 2025 | 0.0708 |
| September 30, 2025 | 0.0747 |
| June 30, 2025 | 0.0761 |
| March 31, 2025 | 0.07 |
| December 31, 2024 | 0.082 |
| September 30, 2024 | 0.1021 |
| June 30, 2024 | 0.1063 |
| March 31, 2024 | 0.1241 |
| December 31, 2023 | 0.1298 |
| September 30, 2023 | 0.1179 |
| June 30, 2023 | 0.1395 |
| March 31, 2023 | 0.1248 |
| December 31, 2022 | 0.171 |
| September 30, 2022 | 0.2035 |
| June 30, 2022 | 0.1703 |
| March 31, 2022 | 0.1447 |
| December 31, 2021 | 0.1151 |
| September 30, 2021 | 0.1036 |
| June 30, 2021 | 0.0702 |
| March 31, 2021 | 0.0834 |
| December 31, 2020 | 0.0787 |
| September 30, 2020 | 0.0153 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0104 |
| March 31, 2020 | 0.0391 |
| December 31, 2019 | 0.0385 |
| September 30, 2019 | 0.0405 |
| June 30, 2019 | 0.0304 |
| March 31, 2019 | 0.024 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AVITA Medical, Inc. | -1.519 |
| Halozyme Therapeutics, Inc. | -58.84 |
| CareDx, Inc. | 0.062 |
| Merck & Co., Inc. | 1.198 |
| SELLAS Life Sciences Group, Inc. | 0.0054 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 991.21M |
| Total Liabilities (Quarterly) | 178.55M |
| Shareholders Equity (Quarterly) | 812.66M |
| Current Ratio | 5.196 |
| Net Debt Paydown Yield | 0.02% |